| |
|
|
|
TRACON Pharmaceuticals Inc.  
|
|
1.1 -0.03 (-0.03%) |
12-10 16:00 |
|
Open: |
1.15 |
Pre close: |
1.13 |
Target:
|
1.64 
|
|
High: |
1.18 |
Low: |
1.0865 |
Resistance:
|
1.40
1.63
|
|
Volume: |
87,756 |
Market Cap: |
33M |
Support:
|
1.03
0.86
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.22
|
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
1.26 |
Signal(12,26,9): |
-0.10  |
|
MA(100): |
1.87 |
Stochastic Oscillator |
%K(14,3):
|
26.90 |
|
MA(250): |
2.38 |
%D(3): |
39.47 |
|
Average Volume(K) |
3-Month: |
11602
|
52-Week |
High:
|
3.60 |
|
10-Days: |
18149 |
Low: |
1.03 |
|
RSI |
RSI(14):
|
33.07 |
Change(%): |
-63.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.460 |
Return on Equity (ttm) |
-134.1 |
Shares Out. (M) |
29.87 |
|
EPS Est. Current Year |
-1.570 |
Return on Assets (ttm) |
-78.6 |
Shares Float (M) |
29.69 |
|
EPS Est. Next Year |
-1.830 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.60 |
|
EPS Est. Next Quarter |
-0.490 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
51.90 |
|
Forward EPS |
-1.527 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.300 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.75 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.85 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-24.97 |
P/S |
252746160.00 |
|
Operating Margin |
-1112.10 |
Levered Free Cash Flow
(M) |
-12.58 |
P/CF |
-1.32 |
|
|
|
|
|
|
